Equity Analysis /
United States of America

US : Flexion Therapeutics, Inc. - FLXN | Positive 1Q21 Zilretta Revenue and Introduced Guidance Reaffirms Recovery Thesis

    Contributors
    Michael Parolari
    Lucas Lee
    CGS-CIMB
    14 April 2021
    Published by